Nippon Shinyaku Co., Ltd.
ISIN JP3717600005
|WKN 858032
Overview
Description
Nippon Shinyaku Co., Ltd. engages in the manufacture and sale of pharmaceuticals and foodstuffs. Its operations are carried out through the Pharmaceuticals and Functional Food divisions. The Pharmaceuticals division develops and distributes drugs that treat urological diseases, inflammation, allergies, hematological malignancies, cardiovascular and metabolic diseases, and gastrointestinal disorders. The Functional Food division manufactures and supplies health food ingredients, preservatives, protein preparations, nutritional ingredients, seasonings and spices, and sterilization cleaning agents. The company was founded on November 20, 1911 and is headquartered Kyoto, Japan.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Japan
Financials
Key metrics
| Market capitalisation, EUR | 1,552.33 m |
| EPS, EUR | 2.75 |
| P/B ratio | 0.97 |
| P/E ratio | 7.90 |
| Dividend yield | 3.48% |
Income statement (2023)
| Revenue, EUR | 947.50 m |
| Net income, EUR | 165.21 m |
| Profit margin | 17.44% |
What ETF is Nippon Shinyaku Co., Ltd. in?
There are 35 ETFs which contain Nippon Shinyaku Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Nippon Shinyaku Co., Ltd. is the L&G Pharma Breakthrough UCITS ETF.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
